Literature DB >> 26126493

Avβ3 integrin: Pathogenetic role in osteotropic tumors.

Stefania Stucci1, Marco Tucci2, Anna Passarelli1, Franco Silvestris1.   

Abstract

The interplay of cancer cells and accessory cells within the microenvironment drives signals regulating the proliferation, migration and skeleton colonization. Osteotropism of tumor cells depends on chemokine activation, production of soluble factors and defective gene expression that cooperate within the metastatic niche to the bone resorbing functions of osteoclasts. Adhesion of cancer cells to the extracellular matrix is regulated by integrins as αvβ3 that enhances their invasiveness, pro-tumor angiogenesis and skeleton invasion. Therefore, αvβ3 signaling is implicated in enhancing osteotropism of breast and prostate cancers as well as of multiple myeloma. Targeting of αvβ3 has been adopted to restrain the tumor progression in several cancer models leading to improvement of overall survival as effect of the reduction of both tumor burden and osteotropism by malignant cells. Here, we review both the role of αvβ3 in malignant osteoclastogenesis and its potential targeting to restrain the bone colonization by skeleton invading cancers.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bone metastasis; Cancer; Multiple myeloma; Target therapy; α(v)β(3)

Mesh:

Substances:

Year:  2015        PMID: 26126493     DOI: 10.1016/j.critrevonc.2015.05.018

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  18 in total

1.  Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.

Authors:  Amrita Singh; Carmine Fedele; Huimin Lu; Marja T Nevalainen; James H Keen; Lucia R Languino
Journal:  Mol Cancer Res       Date:  2016-07-20       Impact factor: 5.852

2.  Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.

Authors:  Shiv Ram Krishn; Amrita Singh; Nicholas Bowler; Alexander N Duffy; Andrea Friedman; Carmine Fedele; Senem Kurtoglu; Sushil K Tripathi; Kerith Wang; Adam Hawkins; Aejaz Sayeed; Chirayu P Goswami; Madhukar L Thakur; Renato V Iozzo; Stephen C Peiper; William K Kelly; Lucia R Languino
Journal:  Matrix Biol       Date:  2018-08-08       Impact factor: 11.583

Review 3.  Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy.

Authors:  Wiktoria Strasenburg; Jakub Jóźwicki; Justyna Durślewicz; Błażej Kuffel; Martyna Parol Kulczyk; Adam Kowalewski; Dariusz Grzanka; Tomasz Drewa; Jan Adamowicz
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 4.  The vasculature: a vessel for bone metastasis.

Authors:  Koen Raymaekers; Steve Stegen; Nick van Gastel; Geert Carmeliet
Journal:  Bonekey Rep       Date:  2015-09-09

Review 5.  Integrin αvβ3 Signaling in Tumor-Induced Bone Disease.

Authors:  Kristin A Kwakwa; Julie A Sterling
Journal:  Cancers (Basel)       Date:  2017-07-08       Impact factor: 6.639

Review 6.  Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.

Authors:  Ilaria Roato; Riccardo Ferracini
Journal:  Cancers (Basel)       Date:  2018-02-20       Impact factor: 6.639

Review 7.  The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice.

Authors:  Luigia Stefania Stucci; Valeria Internò; Marco Tucci; Martina Perrone; Francesco Mannavola; Raffaele Palmirotta; Camillo Porta
Journal:  Genes (Basel)       Date:  2021-05-13       Impact factor: 4.096

8.  Experimental Adaptation of Rotaviruses to Tumor Cell Lines.

Authors:  Carlos A Guerrero; Rafael A Guerrero; Elver Silva; Orlando Acosta; Emiliano Barreto
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

Review 9.  Exploring the Role of RGD-Recognizing Integrins in Cancer.

Authors:  Markus Nieberler; Ute Reuning; Florian Reichart; Johannes Notni; Hans-Jürgen Wester; Markus Schwaiger; Michael Weinmüller; Andreas Räder; Katja Steiger; Horst Kessler
Journal:  Cancers (Basel)       Date:  2017-09-04       Impact factor: 6.639

10.  Avicequinone B sensitizes anoikis in human lung cancer cells.

Authors:  Arisara Prateep; Somruethai Sumkhemthong; Wiranpat Karnsomwan; Wanchai De-Eknamkul; Supakarn Chamni; Pithi Chanvorachote; Chatchai Chaotham
Journal:  J Biomed Sci       Date:  2018-04-09       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.